Oncology/Hematology

Leukemia

More in Leukemia

Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

News, features, and commentary about cancer-related issues

1 Hr Ago
Onco Break over a computer rendering of a cancer cell.
Sacubitril/Valsartan Curbs Cardiotoxicity From Chemotherapy

Benefit shown in trial of patients flagged for high risk of cardiotoxicity

Nov 20, 2024
AHA over a photo of McCormick Place Convention Center in Chicago, IL.
FDA Approves First Menin Inhibitor for Acute Leukemia

Complete responses in 21% of patients treated with single-agent revumenib

Nov 15, 2024
FDA APPROVED revumenib (Revuforj) over a computer rendering of leukemia cells.
Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

News, features, and commentary about cancer-related issues

Nov 15, 2024
Onco Break over a computer rendering of a cancer cell.
Electronic Symptom Screening in Kids With Cancer Boosts Quality of Care

Improvements seen in pain, neuropathy, and cognitive function

Nov 13, 2024
A photo of a female nurse interacting with a little girl who is receiving chemotherapy.
U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain

Health news and commentary gathered by staff

Nov 11, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
New CAR T-Cell Therapy Approved for Leukemia

Obecabtagene autoleucel has no requirement for a REMS program

Nov 08, 2024
FDA APPROVED obecabtagene autoleucel (Aucatzyl) over a rendering of CAR-T cells attacking lymphoblastic leukemia cells.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

News, features, and commentary about cancer-related issues

Nov 01, 2024
Onco Break over a computer rendering of a cancer cell.
Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

-- News, features, and commentary about cancer-related issues

Oct 18, 2024
Onco Break over a computer rendering of a cancer cell.
Study Details Perinatal Risks of Blood Cancers Diagnosed in Pregnancy

Likelihood of severe maternal morbidity more than 20 times higher versus the general population

Oct 11, 2024
A computer rendering of cancer cells in the blood stream.
Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk

10% of patients in trials leading to eli-cel's approval developed MDS or AML

Oct 09, 2024
A computer rendering of stem cells and a strand of DNA.
Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer

News, features, and commentary about cancer-related issues

Oct 04, 2024
Onco Break over a computer rendering of a cancer cell.
Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

News, features, and commentary about cancer-related issues

Sep 26, 2024
Onco Break over a computer rendering of a cancer cell.
Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

News, features, and commentary about cancer-related issues

Sep 19, 2024
Onco Break over a computer rendering of a cancer cell.
More in Leukemia

1.50 CME Credits
Unleashing Emerging Therapies to Modify Myelofibrosis Pathogenesis: Shifting the Treatment Paradigm to Target Deeper Clinical and Molecular Responses

1.50 CME Credits
Accelerating the Adoption of the Latest Evidence on Sequencing Therapies for Multiple Myeloma Across Practice Settings

1.50 CME Credits
Treatment Crossroads: Diverse Perspectives on Treatment Strategies for Relapsed/Refractory DLBCL and FL

1.00 CME Credits
Decoding Complex Chronic Lymphocytic Leukemia Cases: An Expert TheraTalk

0.75 CME Credits
Ask the Experts: Latest Advances in Treatment of Low-Grade, Intermediate-Risk, Non-Muscle Invasive Bladder Cancer

1.00 CME Credits
Lung Cancer: Applying Evidence-Based Guidelines to Biomarker Driven Treatment Selection in Perioperative Settings

0.25 CME Credits
PARP Prodigy: Mastering Metastatic Castration-Resistant Prostate Cancer

0.75 CME Credits
The Latest Evidence and Barriers to the Integration of Emerging Targeted Therapies in Adult Diffuse Low-Grade Glioma Care